Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
City of Hope Tulsa, formerly known as Southwestern Regional Medical Center, is a comprehensive cancer treatment and research facility located in Tulsa, Oklahoma. As a key regional hub within the City of Hope network, the center provides advanced oncology services including genomic testing, precision medicine, and immunotherapy. The facility is recognized for its integrated care model, which combines traditional clinical treatments with supportive therapies such as nutrition and oncology rehabilitation. It serves as a significant site for clinical trials, offering patients access to emerging therapies in Phase 1 through Phase 3 studies. Following its acquisition by City of Hope in 2022, the center has expanded its research capabilities and specialized expertise in complex cancer care. The institution remains dedicated to the 'Mother Standard' of care, focusing on personalized treatment plans for various cancer types.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Southwestern Regional Medical Center.